10x Genomics, Inc. Class A Common Stock TXG
$90.36
+0.36%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (6 Buy · 9 Hold · 0 Sell)
- Average Price Target
- $51.21
- Implied Upside
- -43.3%
- Price Target Range
- $19.00 – $110.00
- Analysts (12 mo)
- 15
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-28 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $47 → $80 |
| 2026-09-28 | Argus ResearchJohn Eade |
Initiates coverage on | Buy | $110 |
| 2026-09-09 | UBSDan Leonard |
Maintains | Neutral | $20 → $68 |
| 2026-09-01 | RBC CapitalDan Leonard |
Initiates coverage on | Sector perform | $70 |
| 2026-08-12 | Stephens & Co.Mason Carrico |
Maintains | Overweight | $50 → $65 |
| 2026-08-10 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $42 → $47 |
| 2026-08-10 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $50 → $60 |
| 2026-08-07 | CitigroupBrendan Digan |
Maintains | Neutral | $45 → $50 |
| 2026-08-07 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $37 → $40 |
| 2026-07-17 | Leerink PartnersMike Kratky |
Maintains | Market perform | $23 → $40 |
| 2026-07-14 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $32 → $50 |
| 2026-07-09 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $22 → $37 |
| 2026-07-08 | CitigroupPatrick Donnelly |
Maintains | Neutral | $24 → $45 |
| 2026-07-01 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $20 → $42 |
| 2026-06-24 | BarclaysLuke Sergott |
Maintains | Overweight | $30 → $40 |
| 2026-05-12 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $20 → $22 |
| 2026-05-12 | JP MorganCasey Woodring |
Maintains | Neutral | $17 → $20 |
| 2026-04-20 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $22 → $32 |
| 2026-04-20 | B of A SecuritiesDerik De Bruin |
Maintains | Neutral | $21 → $30 |
| 2026-04-14 | BarclaysLuke Sergott |
Maintains | Overweight | $22 → $30 |
| 2026-04-07 | CitigroupPatrick Donnelly |
Maintains | Neutral | $18 → $24 |
| 2026-03-31 | William BlairMatt Larew |
Upgrades | Market perform → Outperform | — |
| 2026-03-02 | StifelDaniel Arias |
Maintains | Buy | $20 → $25 |
| 2026-02-20 | UBSDan Leonard |
Maintains | Neutral | $14 → $20 |
| 2026-02-13 | StifelDaniel Arias |
Maintains | Buy | $15 → $20 |
| 2026-02-13 | TD CowenDan Brennan |
Maintains | Hold | $18 → $19 |
| 2026-01-27 | Leerink PartnersMike Kratky |
Maintains | Market perform | $22 → $20 |
| 2026-01-16 | Leerink PartnersMike Kratky |
Maintains | Market perform | $20 → $22 |
| 2026-01-07 | Leerink PartnersMike Kratky |
Maintains | Market perform | $15 → $20 |
| 2026-01-07 | TD CowenDan Brennan |
Maintains | Hold | $15 → $18 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $90.36
- Market Cap
- $11.77 billion
- 52-Week Range
- $11.16 – $95.16
- Average Volume
- 3.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.